<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Cardio</title>
	<atom:link href="http://www.tapanray.in/tag/cardio/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Drugs &amp; Devices: Chasing Never-Enough Profit And Price Control</title>
		<link>http://www.tapanray.in/drugs-devices-chasing-never-enough-profit-and-price-control/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=drugs-devices-chasing-never-enough-profit-and-price-control</link>
		<comments>http://www.tapanray.in/drugs-devices-chasing-never-enough-profit-and-price-control/#comments</comments>
		<pubDate>Mon, 25 Jul 2016 00:00:07 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[AIIMS]]></category>
		<category><![CDATA[angioplasty]]></category>
		<category><![CDATA[CAD]]></category>
		<category><![CDATA[Cardio]]></category>
		<category><![CDATA[Chasing]]></category>
		<category><![CDATA[coronary]]></category>
		<category><![CDATA[CVD]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[Devices]]></category>
		<category><![CDATA[DPCO]]></category>
		<category><![CDATA[driven]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[never-enough-pr0fit]]></category>
		<category><![CDATA[NLEM]]></category>
		<category><![CDATA[NPPA]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[stent]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[vascular]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7732</guid>
		<description><![CDATA[On July 20, 2016, the Union Ministry of Health of India announced the addition of Coronary Stents to the National List of Essential Medicines (NLEM) 2015 with immediate effect, bringing them under the Drug Price Control Order. Reacting sharply to &#8230; <a href="http://www.tapanray.in/drugs-devices-chasing-never-enough-profit-and-price-control/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/drugs-devices-chasing-never-enough-profit-and-price-control/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
